← All diseases
Liver, kidneys and digestion
Primary sclerosing cholangitis
Would you like to receive a message when there is new research on Primary sclerosing cholangitis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was investigated — and you'll get notified as soon as there is new research on Primary sclerosing cholangitis. View what Premium costs.
Publications and studies (1451)
- A biopsychosocial approach to fatigue in primary sclerosing cholangitis: Potentially modifiable factors in the prospective SOMA.LIV study. (2026/07/17) ♡
- Pemafibrate Improves Cholestatic Markers Regardless of the Presence of Primary Biliary Cholangitis. (2026/07/15) ♡
- Vitamin D supplementation is associated with reduced risk of hepatobiliary malignancy in patients with primary sclerosing cholangitis. (2026/07/15) ♡
- Circulating multi-omic signature of disease severity and cholangiocarcinoma in primary sclerosing cholangitis. (2026/07/15) ♡
- Biliary epithelial changes in pediatric autoimmune hepatitis with normal cholangiography: diagnostic caution for autoimmune sclerosing cholangitis overlap. (2026/07/13) ♡
- High-resolution reconstruction of cell-type-specific transcriptional regulatory processes from bulk sequencing samples. (2026/07/13) ♡
- Epidemiology of primary sclerosing cholangitis in general and IBD populations: a systematic review and meta-analysis. (2026/07/11) ♡
- Leptospira-associated secondary sclerosing cholangitis after acute leptospiral hepatitis. (2026/07/09) ♡
- Association of esketamine exposure with secondary sclerosing cholangitis in critically ill patients: a retrospective cohort analysis of 20,000 ICU cases. (2026/07/08) ♡
- Short, not skinny: The distinct sarcopenia phenotype of pediatric primary sclerosing cholangitis-inflammatory bowel disease. (2026/07/08) ♡
- Primary sclerosing cholangitis displays distinct colonic mucosa topography yet a shared mast cell state with ulcerative colitis. (2026/07/07) ♡
- Rapid resolution of colon inflammation and microbiome remodeling with vancomycin therapy in a patient with primary sclerosing cholangitis. (2026/07/07) ♡
- Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis. (2026/07/06) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Elevated serum IgG4 and eosinophilia in a persistent indeterminate biliary stricture with high-risk features: a case report. (2026/07/06) ♡
- Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis. (2026/07/03) ♡
- Intersectional inequalities in somatic symptom severity: A trans-diagnostic MAIHDA analysis of SOMACROSS data. (2026/07/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rescue Vedolizumab Therapy for a Rare Case of Complicated Severe Ulcerative Colitis: A Case Report and Literature Review. (2026/07/02) ♡
- Prevalence, interreader agreement, and prognostic value of high-grade and relevant strictures in individuals with primary sclerosing cholangitis. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Overlap Syndromes and Associated Immunoglobulin-G4-Related Liver Diseases. (2026/07/01) ♡
- A subset of hepatic fibroblasts marked by Gli1 expression generates portal fibrosis and promotes ductular reaction. (2026/07/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Fibrate therapy in primary sclerosing cholangitis: missing data on lipids, interactions, and cancer risk. (2026/06/30) ♡
- Vanished Without a Trace: A Middle-Aged Man With Vanishing Bile Duct Syndrome-A Case Report. (2026/06/30) ♡
- Elevated Serum Soluble CD137 in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis Highlights a Shared Immunoregulatory Signature. (2026/06/30) ♡
- Reciprocal Serum Phosphatidylcholine Signatures Are Related to Intestinal Inflammation in Inflammatory Bowel Disease and Liver Fibrosis in Primary Sclerosing Cholangitis-An Exploratory Study. (2026/06/30) ♡
- A Multi-omics and Machine Learning Framework Identifies Plasma SBDS as a Causal Biomarker and Therapeutic Target in Primary Sclerosing Cholangitis. (2026/06/28) ♡
- Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)? (2026/06/27) ♡
- Longitudinal GGT Trajectories Identify Prognostic Phenotypes in Paediatric Primary Sclerosing Cholangitis. (2026/06/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of FGF1 in Chronic Liver Diseases. (2026/06/24) ♡
- Inflammatory Cytokines May Mediate the Causal Relationship between Metabolites and Primary Sclerosing Cholangitis: A Bidirectional Mediation Mendelian Randomization Study. (2026/06/23) ♡
- Postoperative detection of Klebsiella pneumoniae in clinical cultures and recurrent primary sclerosing cholangitis after liver transplantation: a single-center retrospective cohort study. (2026/06/22) ♡
- Patterns and Outcomes of Recurrence in Pediatric Langerhans Cell Histiocytosis. (2026/06/20) ♡
- Aberrant p53 overexpression in benign colon biopsies may predict dysplasia risk in patients with primary sclerosing cholangitis and inflammatory bowel disease. (2026/06/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mesenchymal stem cells in intrahepatic and extrahepatic biliary diseases: mechanisms and therapeutic applications. (2026/06/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Treatment of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Comprehensive Review. (2026/06/19) ♡
- Pharmacokinetic modelling of MRI-based liver function for risk assessment in primary sclerosing cholangitis: a prospective pilot study. (2026/06/18) ♡
- Association of FUT2 rs601338 Genotype with Colonic Mucosal Microbiome Composition, Post-Transplant Bacteremia, and All-Cause Mortality After Liver Transplantation for Primary Sclerosing Cholangitis: A Retrospective Cohort Study. (2026/06/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Intrahepatic lithiasis in Western populations: an underrecognized diagnosis and its mimickers. (2026/06/16) ♡
- The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study. (2026/06/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Rare Presentation of Acute Cholecystitis Mimicking Malignancy in a Young Male With Elevated IgG4. (2026/06/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic review of outcomes. (2026/06/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Polymorphic EBV-positive post-transplant lymphoproliferative disorder of the colon mimicking EBV-positive mucocutaneous ulcer: a case report. (2026/06/13) ♡
- Interleukin-8-driven monocyte activation in primary sclerosing cholangitis: Insights from single-cell analysis and humanized immune system mice. (2026/06/12) ♡
- Emerging omics diagnosis of perihilar cholangiocarcinoma. (2026/06/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnostic Imaging of Pancreatic and Biliary Involvement in IgG4-Related Disease: Key Imaging Features, Diagnostic Criteria and Differential Diagnosis. (2026/06/11) ♡
- INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice. (2026/06/09) ♡
- Calculus Bovis ameliorates primary sclerosing cholangitis via a dual-pronged mechanism restoring bile acid and lipid homeostasis in the gut-liver axis. (2026/06/08) ♡
- Multi-Omics Integrative Analysis Identifies the NK Cell-STAT3 Axis as a Shared Immunogenetic Hub Underlying the Comorbidity of Primary Sclerosing Cholangitis and Ulcerative Colitis. (2026/06/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Environmental shaping of tolerance failure in autoimmune liver diseases: a phenotype-specific framework with primary biliary cholangitis as the strongest model. (2026/06/04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A French National Cohort Study Including 571 Patients. (2026/06/01) ♡
- Effectiveness and safety of oral vancomycin in non-primary sclerosing cholangitis paediatric inflammatory bowel disease. (2026/06/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.